Loading... Please wait... Loading... Please wait...
ESTIMATED
05/13/2024
05/13/2024
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 0 | -$0.09 | -$0.09 | -$0.09 |
| Q2 2024 | 1 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2024 | 0 | -$0.18 | -$0.18 | -$0.18 |
| Q4 2024 | 0 | -$0.14 | -$0.14 | -$0.14 |
| Q1 2025 | 0 | -$0.12 | -$0.12 | -$0.12 |
| Q2 2025 | 0 | -$0.09 | -$0.09 | -$0.09 |
| Q3 2025 | 0 | -$0.08 | -$0.08 | -$0.08 |
| Q4 2025 | 0 | -$0.10 | -$0.10 | -$0.10 |
MIRA Pharmaceuticals, Inc. last posted its earnings results on Monday, May 13th, 2024. The company reported $-0.12 earnings per share for the quarter, missing analysts' consensus estimates of $-0.1 by $0.02. The company had revenue of 0 for the quarter and had revenue of 0 for the year. MIRA Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.65 diluted earnings per share) and currently has a price-to-earnings ratio of -1.04. MIRA Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 28th, 2024 based on prior year's report dates.
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue | 05/13/2024 | Q1 2024 | -$0.10 | -$0.09 | 0.01 | $0 | $0 | 04/01/2024 | Q4 2023 | -$0.39 | $0 | $0 | 09/29/2023 | Q3 2023 | -$0.24 | $0 | $0 | 06/29/2023 | Q2 2023 | -$0.09 | $0 | 03/30/2023 | Q1 2023 | -$0.09 | $0 | 12/30/2022 | Q4 2022 | -$43.86 | $0 | 09/29/2022 | Q3 2022 | -$0.12 | $0 | 06/29/2022 | Q2 2022 | -$0.16 | $0 | 03/30/2022 | Q1 2022 | -$0.10 | $0 |
|---|
A. MIRA Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, August 28th, 2024 based off last year's report dates.
A. The conference call for MIRA Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
A. The conference call transcript for MIRA Pharmaceuticals, Inc.'s latest earnings report can be read online.
A. MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) has a recorded net income of $0. MIRA Pharmaceuticals, Inc. has generated $-0.65 earnings per share over the last four quarters.
A. MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) has a price-to-earnings ratio of -1.04 and price/earnings-to-growth ratio is 0.03.
